| __timestamp | Rhythm Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 305409000 |
| Thursday, January 1, 2015 | 3425000 | 377080000 |
| Friday, January 1, 2016 | 6311000 | 432829000 |
| Sunday, January 1, 2017 | 9518000 | 496079000 |
| Monday, January 1, 2018 | 28080000 | 557616000 |
| Tuesday, January 1, 2019 | 36550000 | 658498000 |
| Wednesday, January 1, 2020 | 46125000 | 770456000 |
| Friday, January 1, 2021 | 68486000 | 840100000 |
| Saturday, January 1, 2022 | 92032000 | 944700000 |
| Sunday, January 1, 2023 | 117532000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
Data in motion
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for sustaining growth and innovation. Over the past decade, Vertex Pharmaceuticals Incorporated and Rhythm Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their SG&A expenditures. From 2014 to 2023, Vertex Pharmaceuticals saw a steady increase in SG&A expenses, peaking at approximately $1.14 billion in 2023, reflecting a 272% rise from 2014. This growth underscores Vertex's aggressive expansion and investment in administrative capabilities. In contrast, Rhythm Pharmaceuticals, starting with a modest $1.2 million in 2014, experienced a staggering increase of over 9,500%, reaching around $117 million by 2023. This dramatic rise highlights Rhythm's rapid scaling efforts in a competitive market. These trends offer a fascinating glimpse into the strategic financial management of two leading biotech firms, each navigating the complexities of growth and innovation in unique ways.
Eli Lilly and Company and Vertex Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for AbbVie Inc. and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited Trends and Insights
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or United Therapeutics Corporation
Vertex Pharmaceuticals Incorporated or Ascendis Pharma A/S: Who Manages SG&A Costs Better?
Vertex Pharmaceuticals Incorporated and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Vertex Pharmaceuticals Incorporated and Amicus Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Veracyte, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Viking Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Bausch Health Companies Inc.